29
2023-04-28 18:05:55
AISLA – Italian Amyotrophic Lateral Sclerosis Association crosses the 40-year milestone “With the approval of the new Tofersen therapy we are at a turning point for patients – declares Mario Sabatelli, Clinical Director of NeMO Rome and AISLA Scientific Comm. Pres. – We are happy because it represents a first step to break down this wall of ALS, which seemed insurmountable”.
#therapy #step #breaking #wall